Lyell Immunopharma, Inc. - LYEL
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | ARCH Venture Fund IX, L.P. | 13.9% | 3,247,162 | View |
| May 15, 2026 | SCHEDULE 13G/A | ARCH Venture Fund IX Overage, L.P. | 13.9% | 3,247,162 | View |
| May 15, 2026 | SCHEDULE 13G/A | ARCH Venture Fund XIII, L.P. | 13.9% | 3,247,162 | View |
| May 15, 2026 | SCHEDULE 13G/A | ARCH Venture Partners IX, L.P. | 13.9% | 3,247,162 | View |
| May 15, 2026 | SCHEDULE 13G/A | ARCH Venture Partners IX Overage, L.P. | 13.9% | 3,247,162 | View |
| May 15, 2026 | SCHEDULE 13G/A | ARCH Venture Partners IX, LLC | 13.9% | 3,247,162 | View |
| May 15, 2026 | SCHEDULE 13G/A | ARCH Venture Partners XIII, L.P. | 13.9% | 3,247,162 | View |
| May 15, 2026 | SCHEDULE 13G/A | ARCH Venture Partners XIII, LLC | 13.9% | 3,247,162 | View |
| May 15, 2026 | SCHEDULE 13G/A | Keith Crandell | 13.9% | 3,247,162 | View |
| May 15, 2026 | SCHEDULE 13G/A | Clinton Bybee | 7.8% | 1,820,634 | View |
| May 15, 2026 | SCHEDULE 13G/A | Robert Nelsen | 13.9% | 3,247,162 | View |
| May 15, 2026 | SCHEDULE 13G/A | Kristina Burow | 13.9% | 3,247,162 | View |
| May 15, 2026 | SCHEDULE 13G/A | Steven Gillis | 13.9% | 3,247,162 | View |
| May 15, 2026 | SCHEDULE 13G/A | Paul Berns | 6.1% | 1,426,528 | View |
| May 11, 2026 | SCHEDULE 13G/A | MWG Caph Ltd | 4.3% | 1,008,116 | View |
| May 11, 2026 | SCHEDULE 13G/A | Milky Way Investments Group Ltd. | 4.3% | 1,008,116 | View |
| May 08, 2026 | SCHEDULE 13G/A | Explore Investments LLC | 6.6% | 1,529,054 | View |
| May 08, 2026 | SCHEDULE 13G/A | Jeffrey P. Bezos | 6.6% | 1,529,054 | View |
| Apr 21, 2026 | SCHEDULE 13G | EULER FUND, L.P. | 6.71% | 1,426,528 | View |
| Apr 21, 2026 | SCHEDULE 13G | Euler Managers Limited | 6.71% | 1,426,528 | View |
| Apr 21, 2026 | SCHEDULE 13G | Antonis Indianos | 6.71% | 1,426,528 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.